Augmedix Achieves HITRUST Certification to Further Mitigate Risk in Third-Party Privacy, Security and Compliance
24 August 2023 - 9:00PM
Augmedix (Nasdaq: AUGX), a healthcare technology company that
delivers industry-leading ambient medical documentation and data
solutions, today announced that they have earned certified status
by HITRUST for information security covering their core products,
Augmedix Live and Augmedix Notes, as well as the cloud services
supporting these products.
HITRUST risk-based, two-year (r2) certified status represents an
affirmation that Augmedix’s core products and cloud services have
met demanding regulatory compliance and industry-defined
requirements and that the company is appropriately managing risk.
This achievement places Augmedix in an elite group of organizations
worldwide that have earned this certification. By including federal
and state regulations, standards, and frameworks, and incorporating
a risk-based approach, the HITRUST Assurance Program helps
organizations such as Augmedix address security and data protection
challenges through a comprehensive and flexible framework of
prescriptive and scalable security controls.
“Augmedix takes compliance and information risk management very
seriously, as the protection of patient information and data is a
top priority when developing our product portfolio,” said Manny
Krakaris, Chief Executive Officer of Augmedix. “This certification
further demonstrates Augmedix’s commitment to adopting the most
rigorous measures to ensure patient information is protected within
our platform.”
Augmedix is taking forward-thinking steps to continue to provide
trustworthy, ambient medical documentation and data solutions
through achieving the rigorous HITRUST risk-based, two-year
certification for information security.
“We are pleased to demonstrate to our customers our ability to
address current and emerging industry threats while maintaining
complex compliance, data protection, and privacy requirements,”
said Ashfaq ul Haque, Head of Privacy & Information Security at
Augmedix. “HITRUST Certification is considered the gold standard
because of the control requirements, assurance process, and level
of oversight that ensures accuracy, which collectively make HITRUST
Certification the most comprehensive, transparent, consistent, and
highest quality assessment available.”
About Augmedix
Augmedix (Nasdaq: AUGX) delivers industry-leading, ambient
medical documentation and data solutions to healthcare systems,
physician practices, hospitals, and telemedicine practitioners.
Augmedix is on a mission to help clinicians and patients form a
human connection at the point of care with unobtrusive technology.
Augmedix’s proprietary Notebuilder Platform extracts relevant data
from natural clinician-patient conversations and converts that data
into medical notes in real time, which are seamlessly transferred
to the EHR. The company’s platform uses automatic speech
recognition, natural language processing, including large language
models, and medical documentation specialists to generate accurate
and timely medical notes.
Leveraging this platform, Augmedix’s products relieve clinicians
of administrative burden, in turn, reducing burnout and increasing
both clinician and patient satisfaction. Augmedix is also leading
the revolution in transforming point-of-care information into
valuable structured data that can drive lower revenue cycle
management costs, higher reimbursement levels and deliver important
clinical feedback to the point of care.
Augmedix is headquartered in San Francisco, CA, with offices
around the world. To learn more, visit www.augmedix.com.
Contact Information
Investors:Matt Chesler, CFAFNK
IR646-809-2183augx@fnkir.cominvestors@augmedix.com
Media: Kaila GrafemanAugmedixpr@augmedix.com
Forward-Looking Statements
This press release contains “forward-looking statements” that
involve a number of risks and uncertainties. Such forward-looking
statements include, without limitation, statements regarding the
intended benefits of the HITRUST certification, Augmedix’s
appropriate management of risk and Augmedix’s ability to manage
current and emerging industry threats. Actual results could differ
materially from those stated or implied in forward-looking
statements due to a number of factors, including but not limited
to, risks detailed in our most recent Form 10-K filed with the U.S.
Securities and Exchange Commission on April 17, 2023, as well as
other documents that may be filed by us from time to time with the
U.S. Securities and Exchange Commission. The forward-looking
statements included in this press release represent our views as of
the date of this press release. We undertake no intention or
obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise.
These forward-looking statements should not be relied upon as
representing our views as of any date subsequent to the date of
this press release.
Augmedix (NASDAQ:AUGX)
Historical Stock Chart
From Apr 2024 to May 2024
Augmedix (NASDAQ:AUGX)
Historical Stock Chart
From May 2023 to May 2024